Within this business, the company introduced Gibco CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8, which expanded on Thermo Fisher’s CTS Detachable Dynabeads platform. Meanwhile ...

Industry Prospects Favoring Thermo Fisher Per a Research report, the global cell therapy market was valued at $4.74 billion in 2023 and is expected to expand at a compound annual rate of 22.7% ...

Thermo Fisher has outlaid $2bn to expand manufacturing and development in the US, joining the long list of companies directing resources to domestic operations as ongoing US tariffs risk ...